Product Code: SRP071534
China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of the Chinese adult population had diabetes. These levels, however, have increased to around 12 percent - making it the diabetes capital of the world.
The rise of diabetes in China can be attributed to a number of factors. Driven by a strong economic growth over the past few decades, the Chinese population has become richer, fatter and less mobile. Apart from urbanisation and sedentary lifestyles, Chinese people are also genetically more vulnerable to diabetes compared to Europeans and many other population groups. Other factors such as poor awareness of health issues, high consumption of white rice, poor healthcare infrastructure, etc. have also driven the prevalence of the disease.
China's diabetes statistics may ring alarm bells for the government and healthcare authorities, for drug and diagnostic manufacturers, however, it represents a goldmine. Fuelled by a continuous increase in healthcare expenditures, the market for diabetes drugs and diagnostics is expanding robustly in the country. This is creating lucrative opportunities for global healthcare companies at a time when growth rates in the more developed markets have declined.
IMARC's new report "China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics" provides an analytical and statistical insight into the Chinese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in China. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Chinese diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the China diabetes market in any form.
What we have achieved in this report:
Comprehensive situation analysis of the Chinese diabetes epidemiology and its dynamics:
Focus of the Analysis:
- Historical, current and future prevalence of diabetes in China
- Historical, current and future prevalence of type-1 and type-2 diabetes in China
- Historical, current and future prevalence of diabetes in the urban and rural regions in China
- Historical, current and future prevalence of diabetes among males and females in China
- Historical, current and future prevalence of diabetes among various age groups in China
- Historical, current and future diagnosis rates for diabetes in China
- Historical, current and future drug treatment rates for diabetes in China
Comprehensive situation analysis of the Chinese Oral Antidiabetics market and its dynamics:
Focus of the Analysis:
- Performance of the Oral Antidiabetics market in China
- Performance of key classes
- Performance of key players
- Market outlook
Comprehensive situation analysis of the Chinese Insulin market and its dynamics:
Focus of the Analysis:
- Performance of the Insulin market in China
- Performance of key classes
- Performance of key players
- Market outlook
Comprehensive situation analysis of the Chinese diabetes diagnostics market and its dynamics:
Focus of the Analysis:
- Performance of the diabetes diagnostics market in China
- Market Segmentation
- Key players
- Market outlook
Table of Contents
1 Research Methodology
2 Executive Summary
3 Diabetes Disease Overview
- 3.1 What is Diabetes?
- 3.2 Diabetes Diagnosis and Treatment
- 3.2.1 Diagnosis
- 3.2.2 Treatment
- 3.3 Diabetes Complications
4 KeyFactors Driving the Diabetes Market in China
5 China Diabetes Epidemiology
- 5.1 Diabetes Population and Prevalence Rates
- 5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
- 5.3 Population and Prevalence Rates by Region
- 5.4 Population and Prevalence Rates by Gender
- 5.5 Population and Prevalence Rates by Age Group
- 5.6 Diabetes Diagnosis and Drug Treatment Rates
6 China Diabetes Market
- 6.1 Historical Market Trends (2007-2014)
- 6.2 Market Breakup by Segment (2007-2014)
- 6.3 China Oral Antidiabetics Market
- 6.3.1 Historical Market Trends (2007-2014)
- 6.3.2 Market Breakup by Class (2007-2014)
- 6.3.3 Market Shares of Key Players
- 6.3.4 Market Outlook (2015-2020)
- 6.4 China Insulin Market
- 6.4.1 Historical Market Trends (2015-2020)
- 6.4.2 Market Breakup by Class
- 6.4.3 Market Shares of Key Players
- 6.4.4 Market Outlook (2015-2020)
- 6.5 Market Outlook (2015-2020)
7 China Diabetes Diagnostics Market
- 7.1 Historical Market Trends (2007-2014)
- 7.2 Market Segmentation
- 7.3 Key Players
- 7.4 Market Outlook (2015-2020)
List of Figures
- Figure 3 1: The Impact of Diabetes on the Human Body
- Figure 3 2: Diabetes Complications
- Figure 4 1: China: Overweight & Obese Population (in Millions), 2007, 2014 & 2020
- Figure 4 2: Body Mass Index and Relative Risk of Type-2 Diabetes
- Figure 4 3: Global: Breakup of Diabetes Patients by Region (in %), 2014 & 2030
- Figure 5 1: China: Total Number of Diabetes Patients (in Millions), 2007- 2014
- Figure 5 2: China: Total Number of Diabetes Patients (in Millions), 2015 - 2020
- Figure 5 3: China (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2007- 2014
- Figure 5 4: China (Type1 & Type2): Total Number of Diabetes Patients (in Millions) 2015 - 2020
- Figure 5 5: China (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2007- 2014
- Figure 5 6: China (Urban & Rural): Total Number of Diabetes Patients (in Millions), 2015 - 2020
- Figure 5 7: China (Male & Female): Total Number of Diabetes Patients (in Millions), 2007- 2014
- Figure 5 8: China (Male & Female): Total Number of Diabetes Patients (in Millions), 2015 - 2020
- Figure 5 9: China: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2007- 2014
- Figure 5 10: China: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in Millions), 2015 - 2020
- Figure 5 11: China: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2007- 2014
- Figure 5 12:China: Total Diagnosed & Drug Treated Diabetes Population (in Millions), 2015 - 2020
- Figure 6 1: China: Diabetes Market (in Million US$), 2007-2014
- Figure 6 2: China: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2007-2014
- Figure 6 3: China: Oral Antidiabetics Market (in Million US$), 2007-2014
- Figure 6 4: China: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2007-2014
- Figure 6 5: China: Oral Antidiabetics Market: Sales Share of Key Players (in %)
- Figure 6 6: China: Oral Antidiabetics Market Forecast (in Million US$), 2015-2020
- Figure 6 7: China: Oral Antidiabetics Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020
- Figure 6 8: China: Insulin Market (in Million US$), 2007-2014
- Figure 6 9: China: Insulin Market: Sales Share of Key Classes (in %), 2014
- Figure 6 10: China: Insulin Market: Sales Share of Key Players (in %)
- Figure 6 11: China: Insulin Market Forecast (in Million US$), 2015-2020
- Figure 6 12: China: Insulin Market Forecast: Sales Share of Key Classes (in %), 2015 & 2020
- Figure 6 13: China: Diabetes Market Forecast (in Million US$), 2015-2020
- Figure 6 14: China: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2015-2020
- Figure 7 1: China: Diabetes Diagnostics Market (in Million US$), 2007-2014
- Figure 7 2: China: Diabetes Diagnostics Market Forecast (in Million US$), 2015-2020
List of Tables
- Table 2 1: China: Diabetes Epidemiology: Executive Summary
- Table 2 2: China: Diabetes Market: Executive Summary
- Table 3 1: Diagnosis of Diabetes
- Table 4 1: China: Overweight & Obesity Statistics, 2006, 2010 & 2014
- Table 4 2: China: Urban & Rural Population Breakup (in Millions), 1991, 2001, 2011 & 2014
- Table 4 3: Global: Diabetes Population Breakup by Country (in 000's), 2014 & 2020
- Table 4 4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
- Table 5 1: China: Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
- Table 5 2: China (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
- Table 5 3: China (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
- Table 5 4: China (Male & Female): Total Prevalence & Number of Diabetes Patients, 2007, 2014 & 2020
- Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2007, 2014 & 2020
- Table 5 6: China: Total Diagnosed & Drug Treated Diabetes Population, 2007, 2014 & 2020
